NeOnc Technologies ($NTHI) is a biotech working on drug delivery to hard-to-treat CNS cancers. Their platform aims to overcome the blood-brain barrier and deliver novel therapies like NEO212.
They secured Board approval for a $50 million strategic investment to build a UAE/MENA-based clinical and investment platform. Also, they were included in the Russell Microcap Index which gives them more visibility.
What do you think?
0 nhận xét:
Đăng nhận xét